BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) declared a monthly dividend on Friday, December 6th,NASDAQ Dividends reports. Stockholders of record on Monday, December 16th will be given a dividend of 0.2892 per share on Monday, December 23rd. This represents a $3.47 annualized dividend and a dividend yield of 21.26%. The ex-dividend date is Monday, December 16th. This is an increase from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10.
BlackRock Capital Allocation Term Trust Stock Up 0.1 %
NYSE BCAT traded up $0.01 during mid-day trading on Friday, hitting $16.32. The stock had a trading volume of 528,946 shares, compared to its average volume of 356,651. The firm’s 50 day moving average is $16.20 and its 200 day moving average is $16.32. BlackRock Capital Allocation Term Trust has a twelve month low of $14.68 and a twelve month high of $17.18.
Insider Transactions at BlackRock Capital Allocation Term Trust
In related news, major shareholder Saba Capital Management, L.P. sold 28,670 shares of the stock in a transaction that occurred on Monday, October 21st. The stock was sold at an average price of $16.27, for a total value of $466,460.90. Following the completion of the sale, the insider now owns 14,888,870 shares of the company’s stock, valued at approximately $242,241,914.90. This trade represents a 0.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold 723,927 shares of company stock valued at $11,925,047 over the last 90 days.
About BlackRock Capital Allocation Term Trust
–
Featured Articles
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- Expert Stock Trading Psychology Tips
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 3 Tickers Leading a Meme Stock Revival
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Find and Profitably Trade Stocks at 52-Week Lows
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.